Enfermedad biliar (colelitiasis/colecistitis): Un meta-anlisis de 76 ensayos clnicos randomizados muestra RR 1,37 (mayor riesgo a dosis altas , uso prolongado y cuando se usan para prdida de peso
Scenario 1: Menopausal woman starting both therapies You are 52, postmenopausal, experiencing hot flashes, sleep disruption, and a 30-pound weight gain concentrated around your midsection
Most reproductive endocrinologists recommend pausing GLP-1 medications like semaglutide 4-8 weeks before ovulation stimulation begins
They are produced in the body (e.g
Follow-Up Visits and Outcomes Three-Month Check Weight: Down 3 kg (BMI 34 kg/m) HbA1c: Decreased to 7.8% from 8.6% Blood Pressure: Controlled at 128/80 mmHg Side Effects: Mild nausea during the first few weeks, which subsided with slow dose titration Six-Month Check Weight: Down a total of 6 kg (BMI 33 kg/m) HbA1c: Further improvement to 7.3% Cardiometabolic Indicators: Mild improvement in LDL cholesterol (from 110 mg/dL to 98 mg/dL)
Semaglutide and other GLP-1S are weight-loss injections that are transforming lives